Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Biologics
•
Pulmonology
•
Bronchiectasis
Do you use biologic agents in patients with eosinophilic bronchiectasis?
If so, what is your threshold to start?
Related Questions
How do you manage persistent pseudomonas positive sputum a patient with non-CF bronchiectasis who has chronic sputum production but is otherwise asymptomatic?
Do you treat non-albicans strains of Candida on sputum culture or BAL in patients who are immunosuppressed?
What is your approach to the work up and evaluation of loss of asthma control while on a biologic such as dupilumab?
Is there increased risk with lung SBRT in a patient who has a mild asymptomatic pneumothorax in the field after CT-guided needle biopsy?
What is your preferred agent for fungal prophylaxis in a patient post lung transplant with abnormal LFTs?
Do you administer immunosuppression to patients with idiopathic NSIP who have normal lung function and mild to moderate respiratory symptoms?
Does the experience level of the intubation operator affect outcomes related to pre-oxygenation with NIV versus an oxygen mask?
Do you extend the duration of maintenance therapy past 24 months for patients with ANCA glomerulonephritis who have multiple organ involvement?
What is your approach to evaluation and diagnosis following a non-diagnostic MSLT in a patient with suspected narcolepsy type 2?
Have you adopted the use of low dose morphine for treatment of cough in patients with IPF?
